rentosertib
AssetAlso INS018_055, ISM001-055
Inhibits TNIK kinase to suppress profibrotic signaling and fibrosis.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- Cellular senescence
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Idiopathic pulmonary fibrosis
Phase 3, Recruiting, NCT07687459, clinicaltrials.gov, 8 Oct 2026
In the full profile
- Targets and what it contains2
- Owner and partners1
- Trials1
- Evidence for its targets2
- Competitors12
- Aging relevance1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.